CRISPR Therapeutics (NASDAQ:CRSP) Trading Down 2.9% on Insider Selling
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) fell 2.9% on Thursday after an insider sold shares in the company. The company traded as low as $42.78 and last traded at $42.22. 282,558 shares were traded during trading, a decline of 87% from the average session volume of 2,214,576 shares. The stock had previously closed […]
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) fell 2.9% on Thursday after an insider sold shares in the company. The company traded as low as $42.78 and last traded at $42.22. 282,558 shares were traded during trading, a decline of 87% from the average session volume of 2,214,576 shares. The stock had previously closed […]
